Consensus guidelines for the management of plaque psoriasis. - Wikidata - wikimedia - TriplyDB

Consensus guidelines for the management of plaque psoriasis.

Consensus guidelines for the management of plaque psoriasis.

http://www.wikidata.org/entity/Q34129100

about

Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners Atherosclerosis in psoriatic disease: latest evidence and clinical implications Making the next steps in psoriatic arthritis management: current status and future directions Management of psoriasis patients with hepatitis B or hepatitis C virus infection Patient considerations and targeted therapies in the management of psoriasis in Chinese patients: role of ustekinumab.Efficacy of Methotrexate in patients with plaque type psoriasis Recommendations for a patient-centered approach to the assessment and treatment of scalp psoriasis: a consensus statement from the Asia Scalp Psoriasis Study Group.Use of biologic agents in combination with other therapies for the treatment of psoriasis Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece.Comparison of Treatment Goals for Moderate-to-Severe Psoriasis between Korean Dermatologists and the European Consensus Report.The safety of systemic treatments that can be used for geriatric psoriasis patients: a review Secukinumab.Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant.Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis An evolution in switching therapy for psoriasis patients who fail to meet treatment goals.Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study.Apremilast as a treatment for psoriasis.Systemic therapies for psoriasis: an evidence-based update.Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical review.Treatment of psoriasis: focus on clinic-based management with infliximab.Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis.Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response.Tofacitinib for the treatment of moderate-to-severe psoriasis.Secukinumab: a review in moderate to severe plaque psoriasis.Perioperative management of tumor necrosis factor-alpha blocker-treated psoriatic patients: Case reports and review.Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis.Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology.Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis: A Retrospective Study.Current challenges and emerging drug delivery strategies for the treatment of psoriasis.Ixekizumab: A Review in Moderate to Severe Plaque Psoriasis.Assessing the validity and response distribution of the simplified psoriasis index in patients receiving phototherapy.Incidence and predictors for cardiovascular events in patients with psoriatic arthritis.Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy, safety and tolerability results from a phase 2b randomized controlled trial.More Biologic Therapies Expected To Treat Advanced Plaque Psoriasis.Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.Observational case series on a group of psoriasis patients who failed to respond to any TNF blockers.[Phototherapy in the era of biologicals].Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: a retrospective study.Management of pediatric psoriasis with acitretin: A review.Number needed to treat and costs per responder among biologic treatments for moderate-to-severe plaque psoriasis in Japan.

P2860

Q26771785-FECE768A-6740-4409-B7C5-9285E6EFDC16 Q26783501-95AB1DF5-C47C-4A2A-9F6B-6041C98FA236 Q26783506-82F3001A-0875-4D60-BEAD-63DBA5705549 Q28078157-5266D8E4-7446-4E4A-96C0-A62136777993 Q33800651-77AE66EC-F90A-489C-B4FD-3652D8CB96A4 Q34176219-AAE444F4-3351-4CE5-A8BD-A378B076CED0 Q34452903-6B745F98-8563-4BE3-B87F-8856D08BCDF1 Q34553755-D35B5220-1712-4C67-9D70-B3AA44DED514 Q34944668-1F596AF7-52A3-4A39-8085-FFCDC11240F6 Q35226809-D11D99C6-325B-4093-B015-CBF057AEB017 Q36010949-66DD38A5-E790-46F2-88BF-9740370BB1EA Q36391509-833C64CD-60F3-4A0B-A966-89742197D369 Q36628064-933C977B-4FCB-4365-A578-0F9BB135C7F8 Q36694323-95A43EAD-2546-4952-9DB1-85F7AA5C0461 Q37295966-66157E02-8F4C-42BA-A035-27F0DFBF0903 Q37345488-7C76AB9D-C967-4E08-A5D9-2DAA8A51121D Q38019980-B5443AA3-1FA9-44E1-AC91-CBC822BEE90C Q38185297-7F35945C-BCAE-43FE-B548-CE41C27600EA Q38201788-A4A22877-0336-4B05-AC34-1ECE309EAC3B Q38207916-29BB6069-BE4B-41A8-B439-876C9D4C1C90 Q38231348-078EC027-1870-4DA7-AAA6-9597AA775090 Q38257403-0AD63B62-EF03-485E-808D-CE7484FA143D Q38349779-D1C855EE-0B4C-4C3E-949F-05795C996B23 Q38552526-C722C23E-345B-44D0-9FFF-190AE87ADC59 Q38582507-231670BA-1822-4B52-A518-0D5B7B81A039 Q38673099-D847C7C6-72D3-4028-8DDB-AB39197D2567 Q38712213-1B2293C4-3956-42B8-A707-61BAAD61E02F Q38723865-3E730C47-AFB7-4970-9C0E-EEE79ED9D1B2 Q38831055-0E24304E-9BC7-4DA5-895F-AEBBC61E3014 Q38990571-4B7DA3F4-2014-475D-A1B2-C5A5902F6264 Q39300408-95B05DE6-7A30-4C31-95A8-02C8D7321FF5 Q41192726-FC018781-BC4C-4427-A5F7-DFA6551F9F22 Q41540546-F5977B91-F552-45ED-84CC-0A28985EC268 Q41967507-0079CB5D-C972-4209-8EF1-1FDFD6A51095 Q43116514-0ECD840B-E11F-4BA4-A641-E2D18F5D068C Q43613356-1F25BA1C-552F-417F-BC14-073380D8C6B6 Q43872006-C8C56C65-EB12-4DBD-B925-2C60BC3001B6 Q46972953-01DF56B2-62C1-45B7-8702-51E54CABAF54 Q47671540-5390B39D-71F2-4B18-B7D5-68D52F08B8DE Q48023865-6388DD9A-D859-42DA-B1B8-D9D05FFCDE13

P2860

Consensus guidelines for the management of plaque psoriasis.

http://www.wikidata.org/entity/Q34129100

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Consensus guidelines for the management of plaque psoriasis.

@ast

Consensus guidelines for the management of plaque psoriasis.

@en

Consensus guidelines for the management of plaque psoriasis.

@nl

type

label

Consensus guidelines for the management of plaque psoriasis.

@ast

Consensus guidelines for the management of plaque psoriasis.

@en

Consensus guidelines for the management of plaque psoriasis.

@nl

prefLabel

Consensus guidelines for the management of plaque psoriasis.

@ast

Consensus guidelines for the management of plaque psoriasis.

@en

Consensus guidelines for the management of plaque psoriasis.

@nl

P1433

Q34129100-5D0A3F01-A016-4BAA-B81A-D999238B1CE4

P1476

Q34129100-92340F22-A8CE-4257-9745-7F766FF5109E

P2093

Q34129100-0B727516-13D8-4B87-919F-0B3DB87E0109

Q34129100-0F46FF02-1B58-4C45-B553-F744B56EA77C

Q34129100-19CE599D-CA73-4A6D-BA60-8A63084F2D07

Q34129100-1EAEED6D-CC0D-4DD5-82DB-A168CDF98848

Q34129100-291B0942-656A-469A-855D-BBDFDD5C6317

Q34129100-2BD41EC8-8F7E-4E2C-B3C6-3EE49BDA3604

Q34129100-2BDDADD2-57E5-4BA6-93FE-1E90893EB918

Q34129100-2E14747C-3A3A-4A00-8BCF-2E5F33AB2E1E

Q34129100-3008D76B-3FBF-4CE2-B735-DF3B641A77C1

Q34129100-3706AEFE-E44C-40FF-8FD1-706874220798

P304

Q34129100-C0EBA5B6-650F-49F4-9734-E0CC81CF1B01

P31

Q34129100-A147225E-ECDD-4DC2-9A04-F7F846760031

P356

Q34129100-5A93D3C3-340E-4C70-BFE0-B0341F6941B7

P433

Q34129100-14A63206-F2CD-4B88-BDF6-65678FAC6692

P478

Q34129100-63429466-3570-4A3C-8AF0-5ADB45670025

P50

Q34129100-211280C8-B1F6-48C4-AF02-49106366B497

Q34129100-35F76889-7BDA-4452-B685-814E464064F3

Q34129100-52E206CA-4841-4B0F-B184-C0D668355BE1

Q34129100-B44AE37D-4B8D-410F-99C0-5B4B0AE32FC4

P577

Q34129100-AFD31983-918B-4369-987D-BBF26505A2BB

P5875

Q34129100-299C098E-378B-452F-8151-8165B63A012D

P698

Q34129100-44C029E4-C4EC-4FD5-8AB8-56EDC8567D8D

P356

ARCHDERMATOL.2011.1410

P1433

JAMA Dermatology

P1476

Consensus guidelines for the management of plaque psoriasis

@en

P2093

Abby S Van Voorhees

http://www.w3.org/2001/XMLSchema#string

Alice B Gottlieb

http://www.w3.org/2001/XMLSchema#string

Andrew Blauvelt

http://www.w3.org/2001/XMLSchema#string

Arthur Kavanaugh

http://www.w3.org/2001/XMLSchema#string

Bruce E Strober

http://www.w3.org/2001/XMLSchema#string

Bruce F Bebo

http://www.w3.org/2001/XMLSchema#string

Carmen Jacobsen

http://www.w3.org/2001/XMLSchema#string

Christopher T Ritchlin

http://www.w3.org/2001/XMLSchema#string

Gerald G Krueger

http://www.w3.org/2001/XMLSchema#string

Jeffrey Crowley

http://www.w3.org/2001/XMLSchema#string

P304

95-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHDERMATOL.2011.1410

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P50

Steven R. Feldman

David Fiorentino

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221752319

http://www.w3.org/2001/XMLSchema#string

P698

22250239

http://www.w3.org/2001/XMLSchema#string